[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@DoodadDoctor Avatar @DoodadDoctor Dr. Rajiv Doodad

Dr. Rajiv Doodad posts on X about $gpcr, $vktx, $wve, $guts the most. They currently have XX followers and XX posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

Mentions: X #

Mentions Line Chart

Followers: XX #

Followers Line Chart

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence finance XXXX% stocks XXXX%

Social topic influence $gpcr #22, $vktx 11.76%, $wve #85, $guts #6, $tvtx 5.88%, $ptgx 5.88%, $mdgl 5.88%, acquisition 5.88%, has been 5.88%, $rvmd XXXX%

Top accounts mentioned or mentioned by @bigchodu @bioinvestor24 @unsureoptimist @biotech2k1 @wallstsai @getoutofmyway1 @daytraderdex @logicalthesis @tradingsssss @unemon1 @vulpescap @bionavgator @jfais20 @andersresearch @smx778939928 @coinbasedbtc @jw929204

Top assets mentioned Viking Therapeutics, Inc (VKTX) Wave Life Sciences Ltd. Ordinary Shares (WVE) Travere Therapeutics, Inc. Common Stock (TVTX) Protagonist Therapeutics, Inc (PTGX) Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) Revolution Medicines, Inc. Common Stock (RVMD) Novo-Nordisk (NVO) Amgen, Inc. (AMGN) Eli Lilly and Company (LLY) Synthetify (SNY) AltLayer (ALT) Terns Pharmaceuticals, Inc. Common Stock (TERN) Kymera Therapeutics, Inc. Common Stock (KYMR) Ocular Therapeutix, Inc. (OCUL) Arrowhead Research Corporation (ARWR) Biohaven Pharmaceutical Holding Company Ltd. (BHVN)

Top Social Posts

Top posts by engagements in the last XX hours

"@BigChodu @Biotech2k1 lol I remember reading that smh. he does hold some good names though and I usually like his port better than some of the more followed experts on BioX. $TVTX is a winner"
X Link 2025-11-30T19:05Z XX followers, XXX engagements

"PTXG has potential But I prefer $PTGX"
X Link 2025-11-30T18:56Z XX followers, 1568 engagements

"@Bionavgator $MDGL is XXX% getting bought"
X Link 2025-12-05T05:06Z XX followers, XXX engagements

"It appears that BioX is struggling to grapple with $GPCR results and subsequent price action today because the vast majority has been long $VKTX + hyping it up as the top takeout candidate for M&A. Today stings - but acquisition price for $GPCR will be well over $XXX so there is still time to get a share of potential best-in-class oral GLP1 that market has been waiting for"
X Link 2025-12-08T14:57Z XX followers, XXX engagements

"@jfais20 @Anders_Research Just wait until that X% allocation to $RVMD plays out And while Im also long $PEPG it was down -XX% today lol. his returns are being decimated"
X Link 2025-12-03T00:16Z XX followers, XXX engagements

"$GPCR topline take: Strong efficacy clean safety tolerability the only real overhang. XXXX% WL @ 120mg (Phase X dose) = competitive w/ oral GLP-1 class High-dose (180-240mg) hits 14-15% WL best-in-class oral range Safety clean (no DILI/QTc) AE d/c XXXX% @ 120mg = main miss but early titration data encouraging Net: Not perfect but clearly a viable Ph3 asset with leverage if tolerability improves - looking at a potential best in-class oral here"
X Link 2025-12-08T13:35Z XX followers, 1348 engagements

"Here's how players in the obesity-verse closed the day: $NVO $LLY $AMGN $VKTX $RHHBY $GPCR $SNY $ALT $GUTS $WVE"
X Link 2025-12-08T21:35Z XX followers, XXX engagements

"What a day it was in biotech Some BIG movers $WVE $GPCR $ACXP $TERN $KYMR $OCUL $CGEM $NRIX $VNDA $GUTS $ARWR $BHVN $STOK $TSHA $OKUR"
X Link 2025-12-08T21:45Z XX followers, XXX engagements